Survival and Long-Term Biochemical Cure in Medullary Thyroid Carcinoma in Denmark 1997–2014: A Nationwide Study
Author(s) -
Jes Sloth Mathiesen,
Jens Peter Kroustrup,
Peter Vestergaard,
Kirstine Stochholm,
Per Løgstrup Poulsen,
Åse Krogh Rasmussen,
Ulla FeldtRasmussen,
Sten Schytte,
Stefano Christian Londero,
Henrik Baymler Pedersen,
Christoffer Holst Hahn,
Jens Bentzen,
Søren Møller,
Mette Gaustadnes,
Maria Rossing,
Finn Cilius Nielsen,
Kim Brixen,
Anja Lisbeth Frederiksen,
Christian Godballe
Publication year - 2019
Publication title -
thyroid
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.918
H-Index - 142
eISSN - 1557-9077
pISSN - 1050-7256
DOI - 10.1089/thy.2018.0564
Subject(s) - medicine , hazard ratio , population , odds ratio , cohort , retrospective cohort study , proportional hazards model , confidence interval , oncology , cohort study , thyroid carcinoma , thyroid , environmental health
Survival of medullary thyroid carcinoma (MTC) subgroups in relation to the general population is poorly described. Data on the factors predicting long-term biochemical cure in MTC patients are nonexistent at a population level. A nationwide retrospective cohort study of MTC in Denmark from 1997 to 2014 was conducted, aiming to detect subgroups with survival similar to that of the general population and to identify prognostic factors for disease-specific survival and long-term biochemical cure.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom